Human interferon-λ3 is a potent member of the type III interferon family

被引:141
作者
Dellgren, C. [1 ]
Gad, H. H. [1 ]
Hamming, O. J. [1 ]
Melchjorsen, J. [1 ]
Hartmann, R. [1 ]
机构
[1] Univ Aarhus, Struct Biol Ctr, Dept Mol Biol, DK-8000 Aarhus C, Denmark
基金
英国医学研究理事会;
关键词
interferon; antiviral; cytokines; protein refolding; IFN-LAMBDA; EXPRESSION; CELLS;
D O I
10.1038/gene.2008.87
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Type III interferon (IFN) or IFN-lambda is a recently discovered family of IFNs that signal through the same downstream transcription factors as type I IFN but use a separate receptor complex composed of the IL-10R2 and the unique IFN-lambda R1 receptor chains. We have established a simple and efficient expression system to produce highly pure and active IFN-lambda of the three human IFN-lambda isoforms (IFN-lambda 1, -lambda 2 and -lambda 3) and used this to compare the biological activity of the different IFN-lambda subtypes. Surprisingly, we found IFN-lambda 3 to possess the highest specific activity of the human IFN-lambda subtypes, exhibiting a twofold higher activity than IFN-lambda 1 and a 16-fold higher activity than IFN-lambda 2. Furthermore, in comparison with the commercially available preparations of IFN-lambda 1 and -lambda 2, we found our IFN-lambda preparation to be superior in activity.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 21 条
  • [1] Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo
    Ank, N
    West, H
    Bartholdy, C
    Eriksson, K
    Thomsen, AR
    Paludan, SR
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (09) : 4501 - 4509
  • [2] Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells
    Coccia, EM
    Severa, M
    Giacomini, E
    Monneron, D
    Remoli, ME
    Julkunen, I
    Cella, M
    Lande, R
    Uzé, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) : 796 - 805
  • [3] Role of deficient type III interferon-λ production in asthma exacerbations
    Contoli, Marco
    Message, Simon D.
    Laza-Stanca, Vasile
    Edwards, Michael R.
    Wark, Peter A. B.
    Bartlett, Nathan W.
    Kebadze, Tatiana
    Mallia, Patrick
    Stanciu, Luminita A.
    Parker, Hayley L.
    Slater, Louise
    Lewis-Antes, Anita
    Kon, Onn M.
    Holgate, Stephen T.
    Davies, Donna E.
    Kotenko, Sergei V.
    Papi, Alberto
    Johnston, Sebastian L.
    [J]. NATURE MEDICINE, 2006, 12 (09) : 1023 - 1026
  • [4] Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes
    Doyle, Sean E.
    Schreckhise, Heidi
    Khuu-Duong, Kien
    Henderson, Katherine
    Rosler, Robert
    Storey, Harold
    Yao, Lena
    Liu, Hong
    Barahmand-pour, Fariba
    Sivakumar, Pallavur
    Chan, Chung
    Birks, Carl
    Foster, Don
    Clegg, Christopher H.
    Wietzke-Braun, Perdita
    Mihm, Sabine
    Klucher, Kevin M.
    [J]. HEPATOLOGY, 2006, 44 (04) : 896 - 906
  • [5] Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-λ1 -: Similarities with type I interferon signaling
    Dumoutier, L
    Tounsi, A
    Michiels, T
    Sommereyns, C
    Kotenko, SV
    Renauld, JC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (31) : 32269 - 32274
  • [6] Interferons, immunity and cancer immunoediting
    Dunn, Gavin P.
    Koebel, Catherine M.
    Schreiber, Robert D.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (11) : 836 - 848
  • [7] Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response
    Jordan, W. J.
    Eskdale, J.
    Srinivas, S.
    Pekarek, V.
    Kelner, D.
    Rodia, M.
    Gallagher, G.
    [J]. GENES AND IMMUNITY, 2007, 8 (03) : 254 - 261
  • [8] Modulation of the human cytokine response by interferon lambda-1 (IFN-λ1/IL-29)
    Jordan, W. J.
    Eskdale, J.
    Boniotto, M.
    Rodia, M.
    Kellner, D.
    Gallagher, G.
    [J]. GENES AND IMMUNITY, 2007, 8 (01) : 13 - 20
  • [9] IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
    Kotenko, SV
    Gallagher, G
    Baurin, VV
    Lewis-Antes, A
    Shen, ML
    Shah, NK
    Langer, JA
    Sheikh, F
    Dickensheets, H
    Donnelly, RP
    [J]. NATURE IMMUNOLOGY, 2003, 4 (01) : 69 - 77
  • [10] The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions
    Langer, JA
    Cutrone, EC
    Kotenko, S
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (01) : 33 - 48